Zai Lab is a biopharmaceutical company based in China that develops and commercialises medicines for cancer, autoimmune conditions and infectious diseases. It works largely by licensing drug candidates from partners around the world and advancing them through clinical development for patients in China and other markets. Its commercial portfolio includes treatments for ovarian cancer and brain tumours, alongside a pipeline of experimental therapies. The company serves hospitals and patients through its own sales and medical teams, and it also conducts research and development in-house.
On this site Zai Lab Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 9688, with prices in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #216 of 2613 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendStrong
87/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average10.0%
From 52-week high-18.4%
MomentumStrong
73/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return10.9%
6-month return3.3%
12-month, skipping last month-3.4%
Stability (higher is calmer)Fair
54/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)53.7%
Worst drawdown, 1 year (smaller is calmer)-46.7%
LiquidityStrong
93/100
Trades actively.
See the numbers →
Avg daily value traded144.95M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 12.31 – 22.64Daily closes, split-adjusted
Signals
50-day average19.77
200-day average16.16
Golden/death cross (60d)Golden, 45 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.05
Technical summary
Daily
Bearish
3 bullish · 3 neutral · 10 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
18.58
Bearish
EMA 10
18.64
Bearish
SMA 20
19.26
Bearish
EMA 20
19.03
Bearish
SMA 50
19.77
Bearish
EMA 50
18.92
Bearish
SMA 100
17.29
Bullish
EMA 100
18.07
Bearish
SMA 200
16.16
Bullish
EMA 200
17.80
Bearish
Oscillators (daily)
RSI (14)
41.75
Neutral
MACD (12, 26)
-0.38
Bearish
Momentum (12)
-14.52
Bearish
Stochastic %K (14)
25.30
Neutral
Williams %R (14)
-74.70
Neutral
CCI (20)
-161.4
Bullish
Pivot points (classic, last session)
S3
15.76
S2
16.23
S1
17.01
Pivot
17.48
R1
18.26
R2
18.73
R3
19.51
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
